Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01784822 · ClinicalTrials.gov registry record
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
A clinical trial of Ventral Hernias, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- 63
- Enrollment target
- 5
- Study locations
NCT01784822: Completed study of Ventral Hernias, sponsored by Cook Group Incorporated.
NCT01784822 is a study of Ventral Hernias that has completed, run by Cook Group Incorporated. The registered enrollment target is 63 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01784822, a study of Ventral Hernias, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective this study is to collect post-market data on the performance of the Zenapro™ Hybrid Hernia Repair Device when used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
Conditions Studied
Interventions
- DEVICE Zenapro™ Hybrid Hernia Repair Device
Study Locations (5)
North Carolina
- Duke University - Durham
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Tennessee
- University of Tennessee - Knoxville
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-06 |
What the finished NCT01784822 record still lists
NCT01784822 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.
The record links to 1 condition, with Ventral Hernias appearing as the primary indexed condition, and to 1 intervention - of which Zenapro™ Hybrid Hernia Repair Device is the first listed.
NCT01784822 lists 5 locations in 5 states (North Carolina, Ohio, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT01784822 about?
NCT01784822 is a clinical study titled "Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair". The objective this study is to collect post-market data on the performance of the Zenapro™ Hybrid Hernia Repair Device when used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
What is the current status of trial NCT01784822?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2013-02. Estimated completion is 2016-06.
What conditions does trial NCT01784822 study?
This clinical trial studies the following conditions: Ventral Hernias.
What interventions are being tested in trial NCT01784822?
The interventions under investigation include: Zenapro™ Hybrid Hernia Repair Device (DEVICE).
Who is sponsoring clinical trial NCT01784822?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01784822 being conducted?
This trial has 5 study locations across North Carolina, Ohio, Pennsylvania, Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia